The one due in early 2019, I don't think that is delcath. A press release sometime back maybe in a quarterly report, phase 2 trials were terminated as the new ICC phase 3 is the known plan resulting from knowledge gathered.
Lastly don't count on delcath updating regularly that database. There is thus currently only one trial, phase 3 OM for which we wait interim. And phase 3 OM is the only thing in sight that can give this a better market cap